High Body Mass Index (BMI) in North American Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab (R)-CHOP Compensates for Negative Impact of Male Gender

被引：0
|
作者：
Zhou, Zheng [1 ]
Rademaker, Alfred W. [2 ]
Gordon, Leo I. [2 ]
LaCasce, Ann S. [3 ]
Crosby-Thompson, Allison [3 ]
Vanderplas, Ann [4 ]
Abel, Gregory A. [3 ]
Rodriguez, Maria A. [5 ]
Nademanee, Auayporn [6 ]
Kaminski, Mark [7 ]
Czuczman, Myron S. [8 ]
Millenson, Michael M. [9 ]
Niland, Joyce [4 ]
Zelenetz, Andrew D. [10 ]
Friedberg, Jonathan W. [11 ]
Winter, Jane N. [2 ]
机构：
[1] Northwestern Univ, NW Mem Hosp, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[5] UT MD Anderson Canc Ctr, Houston, TX USA
[6] City Hope Natl Med Ctr, Duarte, CA USA
[7] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[8] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[9] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[10] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[11] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] EVALUATION OF THE PROGNOSTIC SIGNIFICANCE OF THE BODY MASS INDEX (BMI) IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) RECEIVING RITUXIMAB-CHOP (R-CHOP) OR SIMILAR IMMUNOCHEMOTHERAPY
    Vassilakopoulos, T.
    Pangalis, G.
    Papageorgiou, S.
    Anastasopoulou, A.
    Verrou, E.
    Dimou, M.
    Petevi, K.
    Boutsikas, G.
    Kanellopoulos, A.
    Papageorgiou, L.
    Kyrtsoni, M.
    Siakantaris, M.
    Kaparou, M.
    Pappas, V.
    Ioannidou, E.
    Zervas, K.
    Papadaki, E.
    Tsaftaridis, P.
    Panayiotidis, P.
    Konstantinou, N.
    Meletis, J.
    Angelopoulou, M.
    HAEMATOLOGICA, 2013, 98 : 140 - 140
  • [2] High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex
    Zhou, Zheng
    Rademaker, Alfred W.
    Gordon, Leo I.
    LaCasce, Ann S.
    Crosby-Thompson, Allison
    Vanderplas, Ann
    Abel, Gregory A.
    Rodriguez, Maria A.
    Nademanee, Auayporn
    Kaminski, Mark S.
    Czuczman, Myron S.
    Millenson, Michael M.
    Zelenetz, Andrew D.
    Niland, Joyce
    Friedberg, Jonathan W.
    Winter, Jane N.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (10): : 1274 - 1281
  • [3] Rituximab and CHOP for elderly patients with diffuse large B-cell lymphoma
    Carol S. Portlock
    Current Oncology Reports, 2003, 5 (5) : 357 - 357
  • [4] Rituximab, bevacizumab (avastin) and CHOP (RA-CHOP) for patients with diffuse large B-cell lymphoma (DLBCL).
    Ganjoo, KN
    Gordon, L
    Robertson, MJ
    Horning, SJ
    BLOOD, 2004, 104 (11) : 389A - 389A
  • [5] IMPROVED SURVIVAL ASSOCIATED WITH INCREASED BODY MASS INDEX (BMI) IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
    Carson, K.
    Mcdonald, J.
    Luo, S.
    Zeringue, A.
    Colditz, G.
    ANNALS OF ONCOLOGY, 2011, 22 : 192 - 192
  • [6] Cell of Origin (COO) Association with High Body Mass Index (BMI) and Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Maignan, Kathleen
    Azzam, Shaked Peleg
    Adamson, Blythe
    Parrinello, Christina M.
    Carson, Kenneth R.
    BLOOD, 2019, 134
  • [7] UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION OVERCOMES A NEGATIVE IMPACT OF MALE GENDER IN HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH R-CHOP
    Cho, H.
    Chung, H.
    Kim, S. J.
    Park, H.
    Lee, J. Y.
    Jang, J. E.
    Kim, Y.
    Cheong, J. W.
    Min, Y. H.
    Kim, J. S.
    HAEMATOLOGICA, 2015, 100 : 663 - 664
  • [8] The impact of Fc-γ receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab
    Ahlgrimm, Manfred
    Pfreundschuh, Michael
    Kreuz, Markus
    Regitz, Evi
    Preuss, Klaus-Dieter
    Bittenbring, Joerg
    BLOOD, 2011, 118 (17) : 4657 - 4662
  • [9] PROGNOSTIC SIGNIFICANCE OF SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CHOP (R-CHOP)
    Go, S. I.
    Park, M. J.
    Kim, H. G.
    Kang, M. H.
    Lee, G. W.
    HAEMATOLOGICA, 2016, 101 : 686 - 687
  • [10] Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
    Mounier, N
    Briere, J
    Gisselbrecht, C
    Emile, JF
    Lederlin, P
    Sebban, C
    Berger, F
    Bosly, A
    Morel, P
    Tilly, H
    Bouabdallah, R
    Reyes, F
    Gaulard, P
    Coiffier, B
    BLOOD, 2003, 101 (11) : 4279 - 4284
12345